Global forskning om tuberkulos och mykobakterier – Team Lina Davies Forsman

Publikationer

Alla gruppmedlemmars publikationer

Review: JOURNAL OF INTERNAL MEDICINE. 2026;299(6):670-693
Immune endotypes in tuberculosis: Keys to decoding disease complexity
Alipoor SD; Guthrie J; Forsman LD; Di Nardo AR; Brighenti S
Article: CLINICAL INFECTIOUS DISEASES. 2026;82(5):e996-e1004
Diagnostic Accuracy of the STANDARD F TB-Feron FIA Assay for Tuberculosis Infection in Vietnam: A Cross-Sectional Study
Nguyen HT; Vo LNQ; Codlin AJ; Forse R; Wingfield T; Annerstedt KS; Maclean EL-H; Creswell J; Kirubi B; Nguyen HB; Dinh LV; Doan HT; Forsman LD; Luong DV; Hoa NB; Trinh HTT; Ha DT; Huong DT; Thanh NT; Han NT; Van NTC; Trang ONH; Thuy TTT; Quang LVN; Huyen BT
Article: PATHOGENS. 2025;14(12):1218
Association of Antimicrobial Susceptibility with Treatment Response in Mycobacterium avium complex Pulmonary Disease
Luo X; Chen Y; Forsman LD; He Y; Yang G; Wei W; Lou H; Wang L; Yao L; Liu Y; Bruchfeld J; Alffenaar J-W; Xu B; Zheng X; Sha W
Article: BMJ OPEN. 2025;15(8):e103199
Understanding tuberculosis among people with tuberculosis through an educational film: a qualitative study
Lundeberg EE; Biermann O; Kuhlin J; Kulane A; Annerstedt KS; Forsman LD
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2025;29(8):340-348
Drug management of TB in the intensive care setting: an international multicentre study
Tiberi S; Akkerman O; Sotgiu G; Saderi L; Kunst H; Carvalho ACC; Munoz-Torrico M; Lui GC-Y; Rendon A; dos Santos MC; Rosso RG; Mendes IC; Mendoza A; Borges MC; Kritski A; Marcoa R; Vieira MA; Hernandez-Cardenas CM; Rahman A; Barrett J; Shah K; Wagrell L; Johnson E; Hall J; Sabir N; Lynn W; Zolfaghari P; Duarte R; Forsman LD; Whittington A; Martin-Lazaro JF; White V; Chen C; Gray A; Brown M; Alffenaar J-WC; Bruchfeld J; Centis R; D'Ambrosio L; Ruslami R; Kerstjens HAM; Zumla A; Ambrosino N; Migliori GB
Letter: CLINICAL INFECTIOUS DISEASES. 2025;80(6):e94-e95
Reply to He et al: Established Association Between Glycemic Control and Anti-Tuberculosis Drug Exposures After Controlling Confounding Effects
Zhu Y; Forsman LD; Chen C; Zhang H; Shao G; Wang S; Wang S; Xiong H; Bruchfeld J; Wang W; Zhu L; Alffenaar J-W; Hu Y
Journal article: OPEN FORUM INFECTIOUS DISEASES. 2025;12(5):ofaf246
Aerosolized Dornase Alfa (DNase I) for the Treatment of Severe Respiratory Failure in COVID-19: A Randomized Controlled Trial
Akesson P; Mellhammar L; Rasmussen M; Inghammar M; Jesperson S; Mansson F; Lundeberg EE; Walles J; Wallberg M; Frigyesi A; Linder A
Article: DIAGNOSTICS. 2025;15(8):1006
Prevalence of Xpert MTB/RIF Ultra Trace Call Results and Associated Risk Factors During Active Tuberculosis Case Finding in Viet Nam: A Programmatic Evaluation
Dinh LV; Tran KT; Codlin AJ; Vo LNQ; Nguyen NTT; Nguyen LP; Forse R; Nguyen HT; Dang TMH; Nguyen LH; Nguyen HB; Creswell J
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2025;29(4):164-170
Population pharmacokinetics and dose evaluation for second-line TB drugs in patients with diabetes
Cao J; Shao G; Zhong H; Forsman LD; Wang S; Dong S; Li X; Ning Z; Cao H; Hu Y
Article: NATURE COMMUNICATIONS. 2024;15(1):10475
PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment
Cross GB; Sari IP; Burkill SM; Yap CW; Nguyen H; Quyet D; Dalay VB; Gutierrez E; Balanag VM; Castillo RJ; Chang CC; Kelleher AD; O'Doherty J; Paton NI
Journal article: ONE HEALTH. 2024;19:100911
Assessment of genetic diversity, tissue tropism, and antigenic properties of Grimsö betacoronavirus in Swedish bank voles (Clethrionomys glareolus).
Fernández Morente S; Li J; Wasberg A; Faria IR; Economou Lundeberg E; Settergren B; Lundkvist Å; Ling J
Article: CLINICAL INFECTIOUS DISEASES. 2024;79(2):524-533
Drug Exposure and Treatment Outcomes in Patients With Multidrug-Resistant Tuberculosis and Diabetes Mellitus: A Multicenter Prospective Cohort Study From China.
Zhu Y; Davies Forsman L; Chen C; Zhang H; Shao G; Wang S; Wang S; Xiong H; Bruchfeld J; Wang W; Zhu L; Alffenaar J-W; Hu Y
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2024;64(4):107302
Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis.
Kuhlin J; Davies Forsman L; Osman A; Skagerberg M; Jonsson J; Groenheit R; Mansjö M; Werngren J; Alffenaar J-W; Schön T; Bruchfeld J
Article: BMJ OPEN. 2024;14(8):e085614
Study protocol: diagnostic accuracy study comparing Cy-Tb and STANDARD F TB-Feron FIA tests for tuberculosis infection diagnosis in Vietnam.
Nguyen HT; Vo LNQ; Codlin A; Forse R; Wingfield T; Sidney K; MacLean EL-H; Creswell J; Kirubi B; Davies Forsman L
Article: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2024;109(3):116277
The diagnostic performance of GeneXpert MTB/RIF in tuberculosis meningitis: A multicentre accuracy study.
Wang C; Forsman LD; Wang S; Wang S; Shao G; Xiong H; Bao Z; Hu Y
Review: PHARMACEUTICS. 2024;16(6):818
New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?
Chen RH; Burke A; Cho J-G; Alffenaar J-W; Davies Forsman L
Journal article: EMERGING INFECTIOUS DISEASES. 2024;30(4):732-737
Nephropathia Epidemica Caused by Puumala Virus in Bank Voles, Scania, Southern Sweden.
Ling J; Lundeberg EE; Wasberg A; Faria IR; Vucicevic S; Settergren B; Lundkvist Å
Letter: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2024;28(4):212-213
Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria
Dahl VN; Burke A; Floe A; Bruchfeld J; Schon T; Wejse CM; Andersen AB; Svensson E; Van Ingen J; Forsman LD
Article: CLINICAL PHARMACOKINETICS. 2024;63(3):269-278
Salivary Therapeutic Drug Monitoring of Antimicrobial Therapy: Feasible or Futile?
Davies Forsman L; Kim HY; Nguyen TA; Alffenaar J-WC
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2024;140:62-69
Second-line antituberculosis drug exposure thresholds predictive of adverse events in multidrug-resistant tuberculosis treatment
Wang S; Forsman LD; Xu C; Zhang H; Zhu Y; Shao G; Wang S; Cao J; Xiong H; Niward K; Schon T; Bruchfeld J; Zhu L; Alffenaar J-W; Hu Y
Article: PHARMACEUTICS. 2024;16(1):144
Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis
Dong S; Shao G; Davies Forsman L; Wang S; Wang S; Cao J; Bao Z; Bruchfeld J; Alffenaar J-WC; Liu J; Hu Y; Wu M
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2023;27(12):885-898
Standards for clinical trials for treating TB
du Cros P; Greig J; Alffenaar J-WC; Cross GB; Cousins C; Berry C; Khan U; Phillips PPJ; Velasquez GE; Furin J; Spigelman M; Denholm JT; Thi SS; Tiberi S; Huang GKL; Marks GB; Turkova A; Guglielmetti L; Chew KL; Nguyen HT; Ong CWM; Brigden G; Singh KP; Motta I; Lange C; Seddon JA; Nyang'wa B-T; Maug AKJ; Gler MT; Dooley KE; Quelapio M; Tsogt B; Menzies D; Cox V; Upton CM; Skrahina A; McKenna L; Horsburgh Jr CR; Dheda K; Marais BJ
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2023;67(10):e0052823-e00523
The in vitro effecteffect of new combinations of carbapenem-ßlactamase inhibitors for MycobacteriumabscessusMycobacterium abscessus
Froberg G; Ahmed A; Chryssanthou E; Davies Forsman L
Article: MICROBIOLOGY SPECTRUM. 2023;11(5):e0178123-e01723
In vitro activity of new combinations of β-lactam and β-lactamase inhibitors against the Mycobacterium tuberculosis complex
Lundeberg EE; Andersson V; Wijkander M; Groenheit R; Mansjo M; Werngren J; Cortes T; Barilar I; Niemann S; Merker M; Koser CU; Davies Forsman L
Article: BMJ OPEN. 2023;13(10):e075383
Correlation of drug exposure and bacterial susceptibility with treatment response for Mycobacterium avium complex lung disease: protocol for a prospective observational cohort study
Zheng X; Wang L; Forsman LD; Zhang Y; Chen Y; Luo X; Liu Y; Bruchfeld J; Hu Y; Alffenaar J-WC; Sha W; Xu B
Article: SCIENTIFIC REPORTS. 2023;13(1):15209
Comparative performance evaluation of QIAreach QuantiFERON-TB and tuberculin skin test for diagnosis of tuberculosis infection in Viet Nam
Vo LNQ; Tran TTP; Pham HQ; Nguyen HT; Doan HT; Truong HT; Nguyen HB; Nguyen HV; Pham HT; Dong TTT; Codlin A; Forse R; Mac TH; Nguyen NV
Article: BMJ OPEN. 2023;13(8):e076076
What matters most? A qualitative study exploring priorities for supportive interventions for people with tuberculosis in urban Viet Nam
Smith I; Forse R; Annerstedt KS; Thanh NT; Nguyen L; Phan THY; Nguyen H; Codlin A; Vo LNQ; Nguyen NTT; Khan A; Creswell J; Pham Huy M; Basu L; Lonnroth K; Nguyen BH; Nguyen VN; Atkins S
Journal article: LANCET INFECTIOUS DISEASES. 2023;23(7):847-855
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial
Cross GB; Sari IP; Kityo C; Lu Q; Pokharkar Y; Moorakonda RB; Thi H-N; Do Q; Dalay VB; Gutierrez E; Balanag VM; Castillo RJ; Mugerwa H; Fanusi F; Kwan P; Chew KL; Paton NI
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2023;27(7):506-519
Clinical standards for the management of adverse effects during treatment for TB
Singh KP; Carvalho ACC; Centis R; D'Ambrosio L; Migliori GB; Mpagama SG; Nguyen BC; Aarnoutse RE; Aleksa A; van Altena R; Bhavani PK; Bolhuis MS; Borisov S; van't Boveneind-Vrubleuskaya N; Bruchfeld J; Caminero JA; Carvalho I; Cho JG; Forsman LD; Dedicoat M; Dheda K; Dooley K; Furin J; Garcia-Garcia JM; Garcia-Prats A; Hesseling AC; Heysell SK; Hu Y; Kim HY; Manga S; Marais BJ; Margineanu I; Martson A-G; Torrico MM; Nataprawira HM; Nunes E; Ong CWM; Otto-Knapp R; Palmero DJ; Peloquin CA; Rendon A; Silva DR; Ruslami R; Saktiawati AMI; Santoso P; Schaaf HS; Seaworth B; Simonsson USH; Singla R; Skrahina A; Solovic I; Srivastava S; Stocker SL; Stukenboom MGG; Svensson EM; Tadolini M; Thomas TA; Tiberi S; Trubiano J; Udwadia ZF; Verhage AR; Vu DH; Akkerman OW; Alffenaar JWC; Denholm JT
Review: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2023;12(3):211-225
The In vitro activity of carbapenems alone and in combination with β-lactamase inhibitors against difficult-to-treat mycobacteria; Mycobacterium tuberculosis, Mycobacterium abscessus, and Mycobacterium avium complex: A systematic review
Andersson V; Froberg G; Dahl V; Chryssanthou E; Giske C; Schon T; Forsman L
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2023;67(5):e0170022-e01722
Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens
Zhu Y; Zhu L; Davies Forsman L; Paues J; Werngren J; Niward K; Schon T; Bruchfeld J; Xiong H; Alffenaar J-W; Hu Y
Article: TUBERCULOSIS. 2023;140:102341
Acquired drug resistance during the turnaround time for drug susceptibility testing impacts outcome of tuberculosis
Zhu J; Liu J; Bao Z; Cao H; Wang S; Li X; Ning Z; Hoffner S; Hu Y; Forsman LD
Article: JOURNAL OF INFECTIOUS DISEASES. 2023;227(6):820-827
A Rough Colony Morphology of Mycobacterium abscessus Is Associated With Cavitary Pulmonary Disease and Poor Clinical Outcome
Hedin W; Froberg G; Fredman K; Chryssanthou E; Selmeryd I; Gillman A; Orsini L; Runold M; Joensson B; Schon T; Forsman LD
Article: FRONTIERS IN PHARMACOLOGY. 2023;14:1022090
Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients
Shao G; Bao Z; Davies Forsman L; Paues J; Werngren J; Niward K; Schon T; Bruchfeld J; Alffenaar J-W; Hu Y
Editorial: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2023;27(2):91-93
Diabetes mellitus and TB - finding strategies to reduce the double burden of disease
Forsman LD; Alffenaar JWC
Article: FRONTIERS IN PHARMACOLOGY. 2023;13:1032674
Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis
Zhang H; He Y; Davies Forsman L; Paues J; Werngren J; Niward K; Schon T; Bruchfeld J; Alffenaar J-W; Hu Y
Editorial: LANCET RESPIRATORY MEDICINE. 2022;10(6):533-536
Optimising tuberculosis care for refugees affected by armed conflicts Comment
Castro KG; Ditiu L; Sahu S; Ntoumi F; Tiberi S; O'Kane CM; Akkerman O; Manika K; Mwaba P; Forsman LD; Petersen E; Aklillu E; Azhar EI; Cirillo DM; Migliori G-B; Abbara A; Zumla A
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2022;26(6):483-499
Clinical standards for the dosing and management of TB drugs
Alffenaar JWC; Stocker SL; Forsman LD; Garcia-Prats A; Heysell SK; Aarnoutse RE; Akkerman OW; Aleksa A; van Altena R; de Onata WA; Bhavani PK; Van't Boveneind-Vrubleuskaya N; Carvalho ACC; Centis R; Chakaya JM; Cirillo DM; Cho JG; Ambrosio LD; Dalcolmo MP; Denti P; Dheda K; Fox GJ; Hesseling AC; Kim HY; Koser CU; Marais BJ; Margineanu I; Martson AG; Torrico MM; Nataprawira HM; Ong CWM; Otto-Knapp R; Peloquin CA; Silva DR; Ruslami R; Santoso P; Savic RM; Singla R; Svensson EM; Skrahina A; van Soolingen D; Srivastava S; Tadolini M; Tiberi S; Thomas TA; Udwadia ZF; Vu DH; Zhang W; Mpagama SG; Schon T; Migliori GB
Article: CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY. 2022;11(5):628-639
A modeling-based proposal for safe and efficacious reintroduction of bedaquiline after dose interruption: A population pharmacokinetics study
Keutzer L; Salehabad YA; Forsman LD; Simonsson USH
Article: EUROPEAN RESPIRATORY JOURNAL. 2022;59(3):2101925
Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China
Zheng X; Forsman LD; Bao Z; Xie Y; Ning Z; Schon T; Bruchfeld J; Xu B; Alffenaar J-W; Hu Y
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2021;27(12):1805-1813
Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study
Hu Y; Zheng X; Forsman LD; Ning Z; Chen C; Gao Y; Zhang Z; Lu W; Werngren J; Bruchfeld J; Hoffner S; Xu B
Article: CLINICAL INFECTIOUS DISEASES. 2021;73(9):e3511-e3517
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis
Kuhlin J; Forsman LD; Mansjo M; Nordvall MJ; Wijkander M; Wagrell C; Jonsson J; Groenheit R; Werngren J; Schon T; Bruchfeld J
Article: CLINICAL INFECTIOUS DISEASES. 2021;73(9):e3520-e3528
Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment Response
Zheng X; Bao Z; Forsman LD; Hu Y; Ren W; Gao Y; Li X; Hoffner S; Bruchfeld J; Alffenaar J-W
Article: PULMONOLOGY. 2021;27(5):403-412
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
Koirala S; Borisov S; Danila E; Mariandyshev A; Shrestha B; Lukhele N; Dalcolmo M; Shakya SR; Miliauskas S; Kuksa L; Manga S; Aleksa A; Denholm JT; Khadka HB; Skrahina A; Diktanas S; Ferrarese M; Bruchfeld J; Koleva A; Piubello A; Koirala GS; Udwadia ZF; Palmero DJ; Munoz-Torrico M; Gc R; Gualano G; Grecu VI; Motta I; Papavasileiou A; Li Y; Hoefsloot W; Kunst H; Mazza-Stalder J; Payen M-C; Akkerman OW; Bernal E; Manfrin V; Matteelli A; Hamdan HM; Marcos MN; Cadinanos Loidi J; Cebrian Gallardo JJ; Duarte R; Escobar Salinas N; Gomez Rosso R; Laniado-Laborin R; Martinez Robles E; Quiros Fernandez S; Rendon A; Solovic I; Tadolini M; Viggiani P; Belilovski E; Boeree MJ; Cai Q; Davidaviciene E; Forsman LD; De Los Rios J; Draksiene J; Duga A; Elamin SE; Filippov A; Garcia A; Gaudiesiute I; Gavazova B; Gayoso R; Gruslys V; Jonsson J; Khimova E; Madonsela G; Magis-Escurra C; Marchese V; Matei M; Moschos C; Nakceriene B; Nicod L; Palmieri F; Pontarelli A; Smite A; Souleymane MB; Vescovo M; Zablockis R; Zhurkin D; Alffenaar J-W; Caminero JA; Codecasa LR; Garcia-Garcia J-M; Esposito S; Saderi L; Spanevello A; Visca D; Tiberi S; Pontali E; Centis R; D'Ambrosio L; van den Boom M; Sotgiuw G; Migliori GB
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2021;65(9):e0072021-10.1128/aac.00721
Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis
Werngren J; Mansjo M; Glader M; Hoffner S; Forsman LD
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2021;108:81-88
Additional drug resistance for Mycobacterium tuberculosis during turnaround time for drug-susceptibility testing in China: A multicenter observational cohort study
Zhu J; Bao Z; Xie Y; Werngren J; Hu Y; Forsman LD; Bruchfeld J; Hoffner S
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2021;87(3):1347-1358
Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort study
Gao Y; Forsman LD; Ren W; Zheng X; Bao Z; Hu Y; Bruchfeld J; Alffenaar J-W
Article: EUROPEAN RESPIRATORY JOURNAL. 2021;57(3):2003463
Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China.
Davies Forsman L; Niward K; Kuhlin J; Zheng X; Zheng R; Ke R; Hong C; Werngren J; Paues J; Simonsson USH; Eliasson E; Hoffner S; Xu B; Alffenaar J-W; Schön T; Hu Y; Bruchfeld J
Article: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2020;1158:122397
Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma
Zheng X; Jongedijk EM; Hu Y; Kuhlin J; Zheng R; Niward K; Paues J; Xu B; Forsman LD; Schon T; Bruchfeld J; Alffenaar J-WC
Preprint: RESEARCH SQUARE. 2020
Validation of the St George’s respiratory questionnaire Vietnamese Version in new pulmonary tuberculosis patients
Nguyen H; Xuan KM; Chi TN; Thanh TN; Do Q
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2020;96:390-397
Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China
Shi W; Forsman LD; Hu Y; Zheng X; Gao Y; Li X; Jiang W; Bruchfeld J; Diwan VK; Hoffner S; Xu B
Article: EUROPEAN RESPIRATORY JOURNAL. 2019;54(6):1901522
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.
Borisov S; Danila E; Maryandyshev A; Dalcolmo M; Miliauskas S; Kuksa L; Manga S; Skrahina A; Diktanas S; Codecasa LR; Aleksa A; Bruchfeld J; Koleva A; Piubello A; Udwadia ZF; Akkerman OW; Belilovski E; Bernal E; Boeree MJ; Cadiñanos Loidi J; Cai Q; Cebrian Gallardo JJ; Dara M; Davidavičienė E; Forsman LD; De Los Rios J; Denholm J; Drakšienė J; Duarte R; Elamin SE; Escobar Salinas N; Ferrarese M; Filippov A; Garcia A; García-García J-M; Gaudiesiute I; Gavazova B; Gayoso R; Gomez Rosso R; Gruslys V; Gualano G; Hoefsloot W; Jonsson J; Khimova E; Kunst H; Laniado-Laborín R; Li Y; Magis-Escurra C; Manfrin V; Marchese V; Martínez Robles E; Matteelli A; Mazza-Stalder J; Moschos C; Muñoz-Torrico M; Mustafa Hamdan H; Nakčerienė B; Nicod L; Nieto Marcos M; Palmero DJ; Palmieri F; Papavasileiou A; Payen M-C; Pontarelli A; Quirós S; Rendon A; Saderi L; Šmite A; Solovic I; Souleymane MB; Tadolini M; van den Boom M; Vescovo M; Viggiani P; Yedilbayev A; Zablockis R; Zhurkin D; Zignol M; Visca D; Spanevello A; Caminero JA; Alffenaar J-W; Tiberi S; Centis R; D'Ambrosio L; Pontali E; Sotgiu G; Migliori GB
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2019;85(10):2341-2350
Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosis
Svensson RJ; Niward K; Forsman LD; Bruchfeld J; Paues J; Eliasson E; Schon T; Simonsson USH
Article: CLINICAL INFECTIOUS DISEASES. 2019;69(8):1394-1402
Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades
Forsman LD; Jonsson J; Wagrell C; Werngren J; Mansjo M; Wijkander M; Groenheit R; Hammar U; Giske CG; Schon T; Bruchfeld J
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2019;83:72-76
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
Akkerman O; Aleksa A; Alffenaar J-W; Al-Marzouqi NH; Arias-Guillen M; Belilovski E; Bernal E; Boeree MJ; Borisov SE; Bruchfeld J; Cadinanos Loidi J; Cai Q; Caminero JA; Cebrian Gallardo JJ; Centis R; Codecasa LR; D'Ambrosio L; Dalcolmo M; Danila E; Dara M; Davidaviciene E; Forsman LD; Rios Jefe JDL; Denholm J; Duarte R; Elamin SE; Ferrarese M; Filippov A; Ganatra S; Garcia A; Garcia-Garcia J-M; Gayoso R; Giraldo Montoya AM; Gomez Rosso RG; Gualano G; Hoefsloot W; Ilievska-Poposka B; Jonsson J; Khimova E; Kuksa L; Kunst H; Laniado-Laborin R; Li Y; Magis-Escurra C; Manfrin V; Manga S; Marchese V; Martinez Robles E; Maryandyshev A; Matteelli A; Migliori GB; Mullerpattan JB; Munoz-Torrico M; Hamdan HM; Nieto Marcos M; Noordin NM; Juan Palmero D; Palmieri F; Payen M-C; Piubello A; Pontali E; Pontarelli A; Quiros S; Rendon A; Skrahina A; Smite A; Solovic I; Sotgiu G; Souleymane MB; Spanevello A; Stosic M; Tadolini M; Tiberi S; Udwadia ZF; van den Boom M; Vescovo M; Viggiani P; Visca D; Zhurkin D; Zignol M
Other: LAKARTIDNINGEN. 2019;116:FFLR
[First case of nephropathia epidemica in southern Sweden].
Economou Lundeberg E; Frisk J
Article: JOURNAL OF INFECTION. 2019;78(1):35-39
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery
Borisov SE; D'Ambrosio L; Centis R; Tiberi S; Dheda K; Alffenaar J-W; Amale R; Belilowski E; Bruchfeld J; Canneto B; Denholm J; Duarte R; Esmail A; Filippov A; Forsman LD; Gaga M; Ganatra S; Igorevna GA; Mastrapa BL; Manfrin V; Manga S; Maryandyshev A; Massard G; Gonzalez Montaner P; Mullerpattan J; Juan Palmero D; Pontarelli A; Papavasileiou A; Pontali E; Leyet RR; Spanevello A; Udwadia ZF; Viggiani P; Visca D; Sotgiu G; Migliori GB
Review: JOURNAL OF INFECTION. 2018;77(6):469-478
Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis
Pradipta IS; Forsman LD; Bruchfeld J; Hak E; Alffenaar J-W
Doctoral thesis: 2018
Novel treatment strategies for multidrug-resistant tuberculosis
Davies Forsman L
Study protocol: BMJ OPEN. 2018;8(9):e023899
Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study
Forsman LD; Niward K; Hu Y; Zheng R; Zheng X; Ke R; Cai W; Hong C; Li Y; Gao Y; Werngren J; Paues J; Kuhlin J; Simonsson USH; Eliasson E; Alffenaar J-W; Mansjo M; Hoffner S; Xu B; Schon T; Bruchfeld J
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(10):2838-2845
Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting
Niward K; Forsman LD; Bruchfeld J; Chryssanthou E; Carlstrom O; Alomari T; Carlsson B; Pohanka A; Mansjo M; Nordvall MJ; Johansson AG; Eliasson E; Werngren J; Paues J; Simonsson USH; Schon T
Article: EUROPEAN RESPIRATORY JOURNAL. 2018;52:pa3672
Outcomes of drug-resistant TB cases undergoing bedaquiline (BQ)-treatment and adjunctive surgery
Borisov SE; D'ambrosio L; Centis R; Dheda K; Alffenaar J-W; Amale R; Belilowski E; Bruchfeld J; Canneto B; Denholm J; Duarte R; Esmail A; Filippov A; Forsman LD; Gaga M; Ganatra S; Anastasia Igorevna G; Mastrapa BL; Manfrin V; Manga S; Maryandyshev A; Massard G; Gonzalez Montaner P; Mullerpattan J; Juan Palmero D; Pontarelli A; Papavasileiou A; Pontali E; Leyet RR; Spanevello A; Tiberi S; Tramontana A; Udwadia ZF; Viggiani P; Visca D; Sotgiu G; Migliori GB
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2018;62(5):e00218
Plasma Levels of Rifampin Correlate with the Tuberculosis Drug Activity Assay
Niward K; Blom LE; Forsman LD; Bruchfeld J; Eliasson E; Schon T; Chryssanthou E; Paues J
Journal article: EUROPEAN RESPIRATORY JOURNAL. 2017;50:oa4852
Bedaquiline (BQ)-containing regimen at the programmatic level for MDR-TB: preliminary results
Borisov SE; Dheda K; Enwerem M; Leyet RR; D'Ambrosio L; Centis R; Sotgiu G; Tiberi S; Alffenaar J-W; Maryandyshev A; Belilowski E; Ganatra S; Skrahina A; Akkerman O; Aleksa A; Amale R; Artsukevich J; Bruchfeld J; Caminero JA; Martinez IC; Codecasa L; Dalcolmo M; Denholm J; Douglas P; Duarte R; Esmail A; Fadul M; Filippov A; Forsman LD; Gaga M; Garcia-Fuertes J-A; Garcia-Garcia JM; Gualano G; Jonsson J; Kunst H; Lau JS; Mastrapa BL; Troya JLT; Manga S; Manika K; Montaner PG; Mullerpattan J; Oelofse S; Ortelli M; Palmero DJ; Palmieri F; Papalia A; Papavasileiou A; Payen M-C; Pontali E; Cordeiro CR; Sadutshang TD; Sanukevich T; Solodovnikova V; Spanevello A; Topgyal S; Toscanini F; Tramontana A; Udwadia ZF; Viggiani P; White V; Zumla A; Migliori GB
Article: EUROPEAN RESPIRATORY JOURNAL. 2017;49(5):1700387
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
Borisov SE; Dheda K; Enwerem M; Leyet RR; D'Ambrosio L; Centis R; Sotgiu G; Tiberi S; Alffenaar J-W; Maryandyshev A; Belilovski E; Ganatra S; Skrahina A; Akkerman O; Aleksa A; Amale R; Artsukevich J; Bruchfeld J; Caminero JA; Carpena Martinez I; Codecasa L; Dalcolmo M; Denholm J; Douglas P; Duarte R; Esmail A; Fadul M; Filippov A; Forsman LD; Gaga M; Garcia-Fuertes J-A; Garcia-Garcia J-M; Gualano G; Jonsson J; Kunst H; Lau JS; Mastrapa BL; Troya JLT; Manga S; Manika K; Gonzalez Montaner P; Mullerpattan J; Oelofse S; Ortelli M; Juan Palmero D; Palmieri F; Papalia A; Papavasileiou A; Payen M-C; Pontali E; Cordeiro CR; Saderi L; Sadutshang TD; Sanukevich T; Solodovnikova V; Spanevello A; Topgyal S; Toscanini F; Tramontana AR; Udwadia ZF; Viggiani P; White V; Zumla A; Migliori GB
Letter: EUROPEAN RESPIRATORY JOURNAL. 2017;49(4):1700173
Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis
Forsman LD; Bruchfeld J; Alffenaar J-WC
Article: EUROPEAN RESPIRATORY JOURNAL. 2017;49(3):1601612
Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis.
Van der Paardt A-FL; Akkerman OW; Gualano G; Palmieri F; Davies Forsman L; Aleksa A; Tiberi S; de Lange WCM; Bolhuis MS; Skrahina A; van Soolingen D; Kosterink JGW; Migliori GB; van der Werf TS; Alffenaar J-WC
Letter: EUROPEAN RESPIRATORY JOURNAL. 2016;48(4):1230-1233
Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe?
Zuur MA; Akkerman OW; Forsman LD; Hu Y; Zheng R; Bruchfeld J; Tiberi S; Migliori GB; Alffenaar J-WC
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2016;60(8):4786-4792
Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China
Zheng X; Zheng R; Hu Y; Werngren J; Forsman LD; Mansjo M; Xu B; Hoffner S
Article: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2015;4 Suppl 1:80-81
Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2015;59(6):3630-3632
Meropenem-Clavulanic Acid Has High In Vitro Activity against Multidrug-Resistant Mycobacterium tuberculosis
Forsman LD; Giske CG; Bruchfeld J; Schon T; Jureen P; Angeby K
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2014;58(12):7557-7559
Intra- and Extracellular Activities of Trimethoprim-Sulfamethoxazole against Susceptible and Multidrug-Resistant Mycobacterium tuberculosis
Forsman LD; Scohn T; Simonsson USH; Bruchfeld J; Larsson M; Jureen P; Sturegard E; Giske CG; Angeby K
Article: SCANDINAVIAN JOURNAL OF FORENSIC SCIENCE. 2013;19(1):10-12
Fatal bupivacaine overdose through intrathecally positioned epidural catheter
Forsman LD; Öström M; Svanström M; Eriksson A
Article: BRITISH JOURNAL OF SPORTS MEDICINE. 2001;35(5):325-328
Skateboarding injuries of today.
Forsman L; Eriksson A
Article: JOURNAL OF MEDICAL ETHICS. 2000;26(4):289.1-289
Medicolegal certificates in investigations of asylum applications
Forsman L; Edston E
Visa fler

Global forskning om tuberkulos och mykobakterier – Team Lina Davies Forsman

Publikationer

Alla gruppmedlemmars publikationer

Medarbetare och kontakt

Gruppledare

Alla medarbetare i gruppen